This trial is completed!
Search for a recruiting clinical trial for your condition
You can access this
clinical trial
if you have
Completion of Three Dose Series of HPV or Improvement in Vaccine Intervals Between HPV Doses
and you are
between 10 and 21
years old
Phase
-
The phase for this study is not defined.
Show me locations

The purpose

The human papillomavirus (HPV) vaccine is routinely recommended for both adolescent girls and boys starting at age 11, although it can be offered as young as 9 years of age. This is a 3-dose series and many adolescents do not complete it after getting the first dose. This study will study how effective it will be to send reminders to parents to schedule an appointment when their child is due for the next dose of HPV. Parents can chose whether they would like a phone call or text message reminder. This study will determine if the reminders work, and if one method is better than another (phone message vs. text message).

Provided treatments

  • Other: Telephone reminder
  • Other: Text Message reminder
Tris trial is registered with FDA with number: NCT01731496. The sponsor of the trial is University of Rochester and it is looking for 749 volunteers for the current phase.
Official trial title:
Improving Communication and Health for Adolescents With Technology - Implementation of Immunization Strategy